LGD-6972

· Ligand Pharmaceuticals

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LGD-6972, covering 2014-09-25 to 2018-01-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus [Phase 2]